Launch

All articles by Launch

Verrica takes out $125M loan to fund long-awaited Ycanth launch
Verrica takes out $125M loan to fund long-awaited Ycanth launch
Marc Iskowitz
July 25, 2023
4:03 pm

Verrica Pharmaceuticals says the funds will power molluscum brand Ycanth’s multichannel launch and support operations into 2025.

Klick unveils Studio K production facility, launches Klick Brands
Klick unveils Studio K production facility, launches Klick Brands
Jack O'Brien
August 24, 2022
5:01 am

The 2022 MM+M Agency 100 honoree also announced a series of new leadership hires.

Rewriting the traditional launch playbook
Rewriting the traditional launch playbook
Dan Rizzo and Aaron Bean
May 4, 2021
5:00 am

For the growing number of HCPs who are digital natives, digital channels provide a more convenient and flexible way to engage in launches moving forward.

Tribal Worldwide Spins Off Health Division
Tribal Worldwide Spins Off Health Division
John Newton
December 10, 2020
5:57 pm

Tribal Health aims to bring a digital, data-driven approach to clients including Gilead, GSK and Medela

Marketers@Home Podcast 12.3.2020: Akili Interactive’s Meghan Rivera
Marketers@Home Podcast 12.3.2020: Akili Interactive’s Meghan Rivera
MM+M Staff
December 3, 2020
2:17 pm

Meghan Rivera reflects on her move to digital therapeutics as well as preparations for the launch of Akili’s first commercial product, a prescription video game approved for use in kids with ADHD.

Sandoz signs on to lead launch of Pear’s digital therapeutics
Sandoz signs on to lead launch of Pear’s digital therapeutics
Marc Iskowitz
April 23, 2018
1:38 pm

A deal with Sandoz to lead the global launch of Pear’s two lead products puts marketing muscle behind the nascent class of ‘prescription digital therapeutics.’

The 2018 pipeline report: Aspiring assets to keep an eye on
The 2018 pipeline report: Aspiring assets to keep an eye on
Sony Salzman
December 4, 2017
2:58 pm

The most promising products in pharma’s pipeline will compete in a landscape that increasingly rewards big risks and places an emphasis on novel mechanisms. That comes with a catch.

Five things for pharma marketers to know: Monday, November 27, 2017
Five things for pharma marketers to know: Monday, November 27, 2017
Virginia Lau
November 27, 2017
3:20 pm

Teva to cut thousands of U.S. jobs; Regeneron drops Eylea combo drug development; insurers, drugstores, and hospitals increasingly teaming up

Five things for pharma marketers to know: Thursday, November 9, 2017
Five things for pharma marketers to know: Thursday, November 9, 2017
Virginia Lau
November 9, 2017
3:25 pm

GSK hires Google biotech exec to lead R&D; Merck gets FDA-approval for CMV therapy; ex-Lilly exec reportedly top HHS secretary pick

Back at Dendreon, Caggiano takes on Provenge’s comeback
Back at Dendreon, Caggiano takes on Provenge’s comeback
Larry Dobrow
May 15, 2017
1:00 am

Jim Caggiano had witnessed Provenge’s birth during an earlier turn at Dendreon and couldn’t understand what went wrong.

  • From Our Partners